Qube Research & Technologies (QRT)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$28.1K Buy
2024
Q3
$167K Buy
2024
Q2
$145K Sell
2024
Q1
$738K Buy
2022
Q3
Sell
2022
Q2
$52K Buy
2021
Q3
Sell
2021
Q2
$429K Buy
2021
Q1
$273K Buy